Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Dermatologic 1

Conditions

Mouth Neoplasms 1 Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 9 fludarabine phosphate 5 fludarabine 5 atezolizumab 4 Paclitaxel 4 Nivolumab 4 Cyclophosphamide 4 Cisplatin 4 Cetuximab 4 Carboplatin 4 durvalumab 3 Specimen Handling 3 Pemetrexed 3 Docetaxel 3 Bevacizumab 3 venetoclax 2 ibrutinib 2 encorafenib 2 binimetinib 2 Trastuzumab 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Practice Guidelines as Topic 2 Platinum 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ipilimumab 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Afatinib × 30 days × Clear all

NCT06897735 2026-06-03

EDDIS-a1

Petrov, Andrey

Phase 1 Terminated

DermatologicHead & NeckThoracic

Lung Neoplasms, Melanoma, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡